In-PharmaTechnologist.com | Codexis hunts next Big Pharma license deal for protein engineering platform In-PharmaTechnologist.com The conclusion of Big Pharma contracts worth $22.5m (€18m) for Codexis' artificial intelligence-driven protein engineering platform did not hinder its 2017 results. Last week, Codexis reported an annual revenue of $50m, marking a 2% increase compared ... |